About
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 19 2026
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
Apr 16 2026
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
Apr 10 2026
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
Mar 17 2026
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
Mar 12 2026
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
Financials
Revenue
$7.14 M
Market Cap
$165.66 M
EPS
-0.33
Translate